Esper Kallas
Esper Kallas is the director of the Instituto Butantan, a prominent biomedical research center in Brazil known for its work on vaccines and immunobiologicals. Recently, he was in the news for announcing the development of a single-dose vaccine for dengue, which is currently under analysis by the Agência Nacional de Vigilância Sanitária (Anvisa). Kallas highlighted that the institute plans to produce 1 million doses of the vaccine within the year, with an additional 100 million doses expected between 2026 and 2027, amidst a public health emergency due to rising dengue cases in São Paulo.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Brazil | 1 | 8.00 | 0.05% | +0% | 211,049,527 | 109,239 | $1,500,000 | 776$ |
| Liechtenstein | 1 | 5.00 | 0.04% | +0% | 38,137 | 14 | $6,900 | 3$ |
| Totals | 2 | 211,087,664 | 109,253 | $1,506,900 | 779$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Liechtenstein:
Esper Kallás was present at the event alongside other officials.
5
Brazil:
Esper Kallas is the director of the Instituto Butantan, which is developing a vaccine for dengue.
8